Q1 earnings reported and stock pops almost $40 a share after hours. Since we sold off Otezla in 2019, their stock is up 67% while ours is down for a 52%.
Great trade off guys. Well played.
Amgen opened this morning at 277 and is now at 314.
and we are entering the one market where patients who need the drug will not take it....Has nothing to do with Otezla. They are entering the obesity drug market, just like all the other successful, non-laying off big pharma companies
That after hours increase was certainly not driven by Otezla. However, in the news for other things that have no impact on your performance https://weartv.com/news/local/warm-may-in-the-forecast-for-northwest-florida#Q1 earnings reported and stock pops almost $40 a share after hours. Since we sold off Otezla in 2019, their stock is up 67% while ours is down for a 52%.
Great trade off guys. Well played.
Amgen opened this morning at 277 and is now at 314.
do we have a 40% share yet? Like we reported in June of 2023?Has nothing to do with Otezla. They are entering the obesity drug market, just like all the other successful, non-laying off big pharma companies
